Meet the Chief
Dr. Karen Ballen is a professor of medicine at UVA School of Medicine and serves as the Chief of the Division of Hematology/Oncology.
Dr. Ballen received her undergraduate degree in history and literature from Harvard College and her doctorate from Dartmouth Medical School. She completed her medical residency at Beth Israel Hospital and a hematology/oncology fellowship at Brigham and Women’s Hospital in Boston, MA. Before joining UVA’s faculty in 2017, Dr. Ballen was the director of the Leukemia Program at Massachusetts General Hospital and a professor of medicine at Harvard Medical School.
Dr. Ballen’s research interests include novel therapeutic strategies for acute leukemia, including immunotherapy and targeted agents. She is an international expert in stem cell transplants, particularly for patients who have difficulty finding a donor. Dr. Ballen started one of the first cord blood banks in the United States, and she has published over 150 articles on transplants and acute leukemia. She is on the advisory committee of the Center for International Blood and Marrow Transplant Research and the chair of the cord blood advisory committee for the National Marrow Donor Program.
In her spare time, Dr. Ballen likes to hike. She and her daughter climbed Mount Kilimanjaro in 2016.
Hematology/Oncology Clinical Faculty
Click on faculty members’ names to go to their profile in the UVA Health System Find A Doctor Directory. Use the back button to return to the Hematology/Oncology website.
UVA Community Oncology Faculty
In addition to cancer care provided at UVA Hospital and Emily Couric Clinical Cancer Center, division faculty see patients at regional locations in Culpeper, Augusta, and Charlottesville (Pantops). The faculty below practice in these locations and have clinical appointments.
Links take you to the UVA Health System Find a Doctor Directory. Use the back button to return to the Division of Hematology-Oncology website.
Hematology-Oncology Research Faculty
Choose a faculty member to view his or her research profile. Links go to the School of Medicine Research Faculty Directory; use the back button to return to the Hem/Onc division website.
Brenin, Christiana M.
Breast cancer clinical trials for early stage and metastatic breast cancer in selected patient populations.
Densmore, John J.
Malignant hematology (lymphoma, myeloma, leukemia)
Dillon, Patrick M.
Development of clinical trials in breast cancer; cancer immunotherapy; cancer survivorship improvement; cancer and aging.
Douvas, Michael G.
Clinical research in hematologic malignancies, fertility preservation, and quality improvement.
Novel therapeutic approaches for urologic cancers including prostate, urothelial and kidney cancers.
Cell signaling and survival pathways, genetic alterations, and development of experimental therapeutics; large granular lymphocyte (LGL) leukemia; acute myeloid leukemia (AML); role of polyamines in normal and neoplastic growth in the skin, upper aerodige
Acute Myeloid Leukemia: molecular and cellular biology events which mediate aberrant epigenetic and transcriptional mechanisms during disease establishment and progression
Gaughan, Elizabeth M.
Melanoma, Head and Neck Cancer, Genitourinary malignancies, Drug development, Cancer Immunotherapy
Gentzler, Ryan D.
Lung cancer, novel therapies, cancer immunology, and targeted therapy
Hall, Richard Delmar
Clinical trial design and development for novel therapeutics and immunotherapy for the treatment of lung cancer.
Keng, Michael K
Clinical trials in hematologic malignancies, including myelodysplastic syndromes and leukemias with special interest in treating the elderly population, determining optimal combinations and timing of targeted agents in MDS and leukemia, and studying patie
Loughran, Jr., Thomas P
Hematologic malignancies; bone marrow disorders; leukemia; large granular lymphocyte (LGL)
Lum, Lawrence G.
Maitland, Hillary S
Hemostasis and thrombosis
Portell, Craig Anthony
Clinical trials in hematologic malignancies including leukemias and lymphomas, with special interest in determining optimal combinations and timing of targeted agents in B-cell leukemias and lymphomas.
Dr. Thakur's research activities are focused on 1) developing new and innovative therapeutic approaches to enhance clinical and anti-tumor immune responses; 2) developing novel strategies to attenuate the immune suppressive cellular and humoral factors.
Reduced intensity conditioning use, pre-transplant co-morbidity assessment.
Williams, Michael E.
Novel therapeutics for lymphoma, CLL, and other hematologic malignancies with a focus in Mantle cell lymphoma.
Below are links to information and required paperwork for individuals who wish to moonlight.
Note: If the individual wishing to moonlight is a current resident or fellow, moonlighting must be approved by BOTH the division (form #1) and by the School of Medicine Graduate Medical Education office (form #2).
The division form should be submitted to: RMoonlight@hscmail.mcc.virginia.edu.
The GME form should be submitted to Diane Farineau or faxed to 434-244-9438. (The contact info is also on the form.)
- DIVISION FORM: Hem-Onc Moonlighting Agreement
- GME FORM: UVA GME Moonlighting Application
Contact RMoonlight@hscmail.mcc.virginia.edu if you have questions about this process.